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Dendritic epidermal T cells (DETC) are CD45+, Thy-l+, 
CD5-, CD8-, CD4- murine lymphocytes that express sur- 
face-bound CD3 antigens associated with T cell receptor y/S 
heterodimers. Using epidermal cells greatly enriched for 
DETC and depleted of Langerhans cells, we found that 
DETC have growth requirements quite different from those 
of accessory cell-depleted lymph node and splenic T cells. 
Although the latter cells strongly proliferate in response to 
phorbol myristate acetate (PMA) + ionomycin, DETC, 
when exposed to interleukin-1 (IL-l), interleukin-3 (IL-3), 
concanavalin A (ConA), PMA, and ionomycin used either 
alone or in combination, do not exhibit significant mitotic 
activity. Recombinant interleukin 2 (rIL-2), albeit ineffective 
by itself, leads to vigorous proliferation of DETC when used 
with either ConA or PMA + ionomycin + IL-l. In contrast, 
the combination of PMA and recombinant interleukin-4 
(rIL-4), which triggers growth of lym h node T cells, does 
not induce proliferation of DETC. A though a portion of P 
proliferating DETC expressed CD8 antigens, essentially 
none bore detectable amounts of surface-bound CD4 or CD5 
antigens, or both. Continuing stimulation of primary DETC 
cultures with lectin/lymphokine-rich media results in the 
propagation of cells with the essential phenotypic features of 
resident DETC.] Invest Dermatol92:763- 768, 1989 
I n 1983, the authors and others [1,2] described a hitherto unrecognized cell system within the murine epidermis. These cells are bone marrow-derived [1,3 - 51, display a highly dendritic morphology in situ, and bear large amounts of the Thy-l alloantigen on their surface [1,2]. They are 
clearly distinct from all other epidermal cells (EC), i.e., keratino- 
cytes (KC), Langerhans cells (LC), and melanocytes, and have been 
referred to as Thy-l + dendritic e idermal cells (Thy-l+DEC) 
[1,2,5,6]. In single EC suspensions, t R ese cells exhibit a round shape 
and comprise only l-2% of all EC [1,2]. 
Although Thy-l +DEC are different from most peripheral T cells 
as evidenced by their lack of CD5, CD4, and CD8 antigens [6], 
compelling evidence exists that they belong to the T cell system: 
they are numerically reduced in athymic mice [ 11; they proliferate in 
response to concanavalin A (ConA) + interleukin 2 (IL-2) [7]; and 
they uniformly express surface-bound CD3 antigens [8]. These 
CD3 antigens are predominantly, if not exclusively, associated with 
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Abbreviations: 
BSA: bovine serum albumin 
CAS: concanavalin A-conditioned rat spleen cell supernatant 
Coti concanavalin A 
DETC: dendritic epidermal T cells (previously termed Thy-l+DEC) 
EC: Epidermal cells 
disulfide-linked 35 kD/45 kD T cell receptor (TCR) y/6 hetero- 
dimers [9]. 
In view of the presence of TCR on the surface of Thy-l +DEC, 
we have recently proposed that these cells should be renamed den- 
dritic epidermal T cells (DETC) [9]. Cells with similar TCR con- 
figurations have been described on a subset of thymocytes [lo- 131, 
peripheral T cells [ 14 - 171, and T cell leukemias [ 181 in humans and 
mice. It appears that, as opposed to lymphoid organs, the adult 
murine epidermis represents a tissue that contains a homogeneous 
population of CD3+, TCR y/6+, TCR et/p- cells (i.e., DETC), but 
is devoid of any other lymphoid elements [8,9]. We, therefore, felt 
that the investigation of activation, growth, and possibly differen- 
tiation requirements of these cells might not only provide a clue as 
to the functional capacity of DETC, but may also be representative 
of the entire system of CD3+, TCR y/6+, CD5-, CD4-, CD8- 
lymphocytes. 
FACS: fluorescence activated cell sorter 
FBS: fetal bovine serum 
FITC: fluorescein-isothiocyanate 
sH-TdR: PH] thymidine 
rIL-1: recombinant interleukin 1 
rIL-2: recombinant interleukin 2 
IL-2: interleukin 2 
IL-3: interleukin 3 
rIL-4: recombinant interleukin 4 
KC: Keratinocytes 
LC: Langerhans cells 
LNT: Lymph node T cells 
NaN,: sodium azide 
PBS: phosphate-buffered saline 
PMA: phorbol myristate acetate 
ST: Splenic T cells 
TCR: T cell receptors 
Thy-l+DEC: Thy-l positive dendritic epidermal cells 
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MATERIALS AND METHODS 
Animals Male C3H/He mice and male Lewis rats were obtained 
from the Versuchstierzucht und- haltung der Universitat Wien, 
Himberg, Austria. 
First Step Antibodies Information provided in Table I includes 
antibody specificities and the concentrations of the antibodies that 
were used for the different procedures. 
FACS Analysis and Conventional Immunofluorescence Mi- 
croscopy The various monoclonal antibodies (Table I) [19-211 
and isotype-matched control reagents were diluted in phosphate- 
buffered saline (PBS) containing 2% bovine serum albumin (BSA) 
and 0.1% sodium azide (NaN,) to the respective working dilutions. 
Cells ( 105) were incubated in 200 ~1 of the diluted first antibody for 
30 min on ice and washed three times with PBS/2% BSA/O.l% 
NaN, before incubation with the appropriate fluorescein (FITC)- 
labeled second antibodies. They included FITC-mouse anti-rat Ig 
kappa light chain (clone 18.5; mouse IgGa,) [22], FITC-F(ab’)a goat 
anti-mouse Ig (Grub antibodies, Scandic, Vienna, Austria), and 
FITC-F(ab’), goat anti-hamster Ig (Cap 
PA). Stained cells were either analyzed g 
el Labs., Cochranville, 
y conventional fluores- 
cence microscopy (Leitz Ortholux II; Wetzlar, F.R.G.) or on a 
fluorescence activated cell sorter (FACS 440; Becton Dickinson, 
Mountain View, CA). 
Cell Preparations Single EC suspensions were prepared from 
mouse ear skin by standard trypsinization procedures as described 
previously [23]. All preparation steps, except trypsinization, were 
performed in RPM1 1640 containing 10% fetal bovine serum (FBS), 
2 mM L-glutamine, and 50 pg/ml gentamycin (all Flow Laborato- 
ries, Irvine, UK). 
Keratinocytes were prepared by treatment of unfractionated EC 
suspensions with anti- Iak and anti-Thy-l.2 monoclonal antibodies 
(working dilution, Table I) for 30 min at 0°C followed by comple- 
ment (C’; Cedarlane, Hornsby, Ontario, Canada) for 60 min at 
37°C. Dead cells were then removed by Lympholyte-M (Cedar- 
lane; optical density 1.087) density gradient centrifugation for 10 
min at 1200 rpm. 
For enrichment of DETC and LC from EC suspensions, single 
EC (2 X 108) were passed over a discontinuous Percoll gradient 
Table I. Antibodies Used for Immunofluorescence and 
Cytotoxicity 
Antibody 
Working Dilution 
Source’ Staining Cvtotoxicitv 
Mouse anti-mouse Thy-l.2 (IgM, 
ascites) 
Rat anti-mouse Thy-l.2 (IgGa,, 
purified antibody) 
Mouse anti-mouse Lyt-1.1 (CD5) 
(IgGab, ascites) 
Rat anti-mouse Lyt-1 (CD5) 
(IgG,, purified antibody) 
Rat anti-mouse Lyt-2 (CD8) 
(IgG,, purified antibody) 
Rat anti-mouse L3T4 (CD4) 
(IgGz, 8 clone GK1.5, ascites) 
Mouse anti-mouse Iak ( IgGab , 
purified antibody) 
Mouse anti-mouse Ly-5.1 (CD45) 
NEN 
BD 
NEN 
BD 
BD 
EMS 
BD 
NEN 
300 1 
100 
- 1 
100 
100 
100 
100 1 
100 
10.000 
- 
10.000 
- 
100 
- 
(IgG,, ascites) ’ 
Rat anti-mouse IL-2 receptor EMS 1100 - 
(CD25) (IgM, clone 7D4, ascites) 
Hamster anti-mouse CD3 (IgG, JAB neat 
clone 145-2Cl1, culture 
supernatant) 
a NEN, New England Nuclear: BD, Becton Dickinson: Antibodies GK 1.5 [19] and 
7D4 [ZO] were kindly provided by Dr. Ethan M. Shevach (EMS; NIAID, Bethesda, 
MD). Clone 145-2Cll [21] was a generous gift from Dr. Jeffrey A. Bluestone (JAB, 
NCI, Bethesda, MD). 
LC enrrched EC THY- 1 ??DEC ennched EC 
b 
THY-l I 
LOG FLUORESCENCE * 
Figure 1. Immunophenotypic features of I-C-enriched EC (=LC) and 
Thy-l+DEC-enriched EC (=DETC). LC-enriched EC (leJipanel)and Thy- 
l+DEC-enriched EC (right panel) were reacted with anti-CD45, anti-Iak, 
and anti-Thy-l.2 monoclonal antibodies, respectively, using an indirect 
immunofluorescence procedure, and were then analyzed by flow cytometry. 
Dead cells were excluded by propidium iodide staining; arrows denote the 
position of the cut-off channel fixed with the negative control. LC-enriched 
EC are Thy-l- (3%;C), but many of them bear CD45 (68%;A) and Ia 
antigens (42%;B). In contrast, Thy-l+DEC-enriched EC are Ia- (5%;E), but 
most of them bear CD45 (87%;D) and Thy-l (90%;F) antigens. 
(Pharmacia, Uppsala, Sweden; Percoll/RPMI 1640 containing 
0.25 M sucrose) consisting of a 20% and 40% fraction of 15 ml 
each, in 50-ml Falcon tubes (Becton Dickinson, Oxnard, CA). After 
centrifugation at 1200 rpm for 10 min, cells of the interface be- 
tween the Percoll fractions were recollected and treated with anti- 
Thy-l.2 + C’. Cells in the pellet were first subjected to a l-min 
osmotic shock treatment with distilled water, which resulted in lysis 
of more than 95% of the EC (predominantly differentiating KC). 
Subsequently, they were either treated with anti-Iak + C’ alone or 
with both anti-Lyt-1.1 and anti-Ia’+ C’. Both the original interface 
and the pellet fraction were then freed of dead cells by centrifuga- 
tion over Lympholyte-M. Cells dervied from the interface fraction 
were substantially enriched for CD45+, Ia+, Thy-1.2- cells (Fig 1 
A,B,C). This cell population will be further referred to as LC (the 
extent of enrichment ranged between 35%-70%). Cells from the 
pellet fraction were greatly enriched for CD45+, Thy-1.2+, Ia- 
cells (Fig 1 D,E,F). This cell population contained large numbers of 
CD3+ cells, but no CD5+, CD4+, or CD8+ cells (data not shown) 
and will be further referred to as DETC (the quality of enrichment 
ranged between 60%-90%). The viability of the EC suspensions 
and their sub opulations was consistently > 95% as assessed by try- 
pan blue exe P usion. 
Purified peripheral T cells were prepared by passing unseparated 
lymph node or spleen cells through a nylon wool column. Nonad- 
herent effluent cells were subsequently treated with anti-IaL + C’. 
These cells were designated lymph node T cells (LNT) and splenic 
T cells (ST), respectively. Their viability was always > 99%. 
Producton of Lymphokine-rich ConA-activated Rat Spleen 
Cell Supernatants (CAS) Lewis rats were killed by ether anes- 
thesia, their spleens were removed, and single cell suspensions were 
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prepared by mechanical agitation. After red cell lysis with ammo- 
nium-chloride buffer, cells were frequently washed in FBS-supple- 
mented RPM1 1640 and adjusted to a concentration of 10 X 106/ 
ml. They were then cultured for 36 h in RPM1 1640 containing 
10% FBS, 2 mM L-glutamin, 50 pg/ml gentamycin, 100 U/ml 
penicillin (Flow Labs), 100 pg/ml streptomycin (Flow Labs), 0.25 
pug/ml amphotericin (Flow Labs), 1 mM sodium pyruvate (Flow 
Labs), 0.1 mM nonessential amino acids (Flow Labs), 25 mM Hepes 
buffer (Flow Labs), 5 X 10D5 M 2-mercaptoethanol (Gibco, Grand 
Island, NY), lOpg/ml ConA (Pharmacia), and 1 pg/ml indometh- 
acin (Sigma Chem. Corp., St. Louis, MO) in 5% CO,/95% air. 
Thereafter, culture supernatants were collected by centrifugation of 
the cell suspension, sterile-filtered, and stored at -20°C until 
further use. 
Cell Proliferation Assays and Growth Factors Epidermal 
cells, LC, KC, DETC, LNT, or ST (5 X 103, 5 X lO’/well) were 
cultured in 96 well round-bottom microtiter plates (Flow Labs), in 
the presence or absence of one or more of the following agents 
(depicted in final concentrations): Con A (2.5 or 5 fig/ml), phorbol 
myristate acetate (PMA; Sigma; 10 ng/ml), ionomycin (Calbio- 
them; La Jolla, CA, 500 ng/ml), recombinant human interleukin- 
Ia! (rIL-1; Genzyme Corp., Boston, MA, 5 U/ml), recombinant 
human interleukin-2 (rIL-2; Amgen Biol., Thousand Oaks, CA, 50 
or 100 U/ml), recombinant murine interleukin-4 (rIL-4; Genzyme 
Corp.; 200 U/ml), p uri e murine interleukin-3 (IL-3; Genzyme ‘fi d 
Corp.; 20 U/ml), 10% or 20% CAS. Culture medium consisted of 
RPM1 1640 containing 10% FBS, 2 mM L-glutamine, 0.1 mM 
nonessential amino acids, 1 mM sodium pyruvate, 25 mM Hepes 
buffer, 50pg/ml gentamycin, 5 X 10s5 M 2-mercaptoethanol, and 
1 pg/ml indomethacin. Triplicate cultures were incubated at 37°C 
in 5% CO, for 4 - 5 d (inspection of the cultures had revealed signif- 
icant cell growth on these days). Proliferation was assessed by 
[3H]thymidine uptake (1 &i 3H-TdR/well; NEN, Boston, MA) 
during the last 12 h of the culture period. The data are expressed as 
mean cpm of triplicate samples. 
RESULTS 
DETC Are the Only Epidermal Cells To Proliferate in Re- 
sponse to ConA + rIL-2 It has been previously reported that 
DETC-enriched EC proliferate vigorously to ConA + IL-2, 
whereas DETC-depleted EC fail to do so [7]. Using a different 
enrichment procedure, we have obtained similar results, which are 
depicted in Table II. Using 5 X IO’ cells/well, we observed in three 
individual ex 
P 
eriments that unseparated EC (column 1) undergo 
marked proli eration in response to ConA and rIL-2, but only weak 
proliferation when stimulated with either ConA (5 ,ug) or CAS 
alone. No proliferation was observed with rIL-2. All these agents 
failed to induce proliferation above background in KC and LC 
(columns 2, 3)‘. DETC showed vigorous proliferation to ConA + 
rIL-2 and, to a lesser extent, in response to ConA alone and to CAS 
Table II. Proliferative Response of EC, LC, KC, and DETC to 
ConA, rIL-2, and CAS: Representative Experiment 
Responding Cell Populations’ 
[sH]Thymidine Uptake, cpm 
Supplements Added EC KC LC’ DETCd 
Medium .118’ 3,714 1,371 1,098 
ConA (5 fig) 2,430 2,964 882 20,514 
ConA (2.5 pg) 880 NTb 1,041 6,610 
ConA (2.5 pg) + rIL_2 (50 U) 9,023 2,220 1,496 39,045 
rIL-2 (50 U) 970 3,433 488 1,545 
CAS 10% 1,559 5,062 1,843 17,644 
* The different cell populations were seeded in 96 well round-bottom microtiter 
plates at a density of 5 X 10’ cells/well. 
b NT = not tested. 
c Contained 42% la+ cells. 
d contained 90% Thy-l+ cells. 
c SEM were regularly < 15% and are omitted for clarity. 
Table III. Comparison of DETC and ST in Their Proliferative 
Response to rIL-1, rIL-2, IL-3, and ConA 
Responding Cell Populations’ 
PH]Thymidine Uptake, cpm 
Supplements Added 
Experiment 1 
DETCb ST 
Experiment 2 
DETC’ 
ConA (5 pg) 
ConA (2.5 fig) 
ConA (2.5 pg) + rIL-1 (5 U) 
ConA (2.5 pg) + rIL-2 (100 U) 
ConA (2.5 fig) + IL-3 (20 U) 
ConA (2.5 pg) + rIL-1 
(5 U) + rIL-2 (100 U) 
ConA (2.5 pg) + rIL-1 
(5 U) + IL-3 (20 U) 
ConA (2.5 pg) + rIL-2 
(100 U) + IL-3 (20 U) 
rIL-1 (5 U) 
rIL-2 (100 U) 
IL-3 (20 U) 
rIL-1 (5 U) + rIL-2 (100 U) 
rIL-1 (5 U) + IL-3 (20 U) 
rIL-2 (100 U) + IL-3 (20 U) 
rIL-1 (5 U) + rIL-2 (100 U) + 
IL-3 (20 U) 
Medium 
890d 3,111 1,576 
115 179 1,277 
283 1,796 2,589 
26,071 86,731 14,102 
840 1,634 2,473 
28,838 55,529 15,723 
506 3.951 5,689 
26,163 98,058 14,725 
310 992 1,994 
511 843 2,022 
277 4,125 1,858 
677 718 2,562 
286 2,802 2,069 
327 2,222 2,916 
630 733 2,706 
186 89 1,575 
a Cells were seeded in 96 well round-bottom microtiter plates at a density of 5 X 1P 
cells/well. 
b Containing 86% Thy-l+ cells. 
c Containing 67% Thy-l+ cells. 
d SEM were regularly < 15% and are omitted for clarity. 
(column 4). These data demonstrate that 1) the capacity of EC to 
proliferate in response to ConA + rIL-2 resides within a CD45+, 
Thy-l +, Ia- cell population, most likely DETC and 2) that Ia-bear- 
ing LC are not required for the occurrence of this event. 
Activation and Growth Factor Requirements of DETC as 
Compared With ST and LNTt Because even minute numbers 
of passenger T cells possibly present in the DETC-enriched cell 
population, which might lead to erroneous conclusions about the 
actual activation requirements of DETC, we used 5 X IO3 insteadof 
5 X IO’ cells/well, and in certain experiments, the enrichment pro- 
cedure for DETC included the use of both anti-Iak + C’ and anti- 
Lyt-1.1 + C’. 
As demonstrated in Table III, ConA + rIL-2 induced vigorous 
proliferative activity in both DETC and ST. ConA or rIL-2 alone, as 
well as a combined use of ConA and either rIL-1 or IL-3, or both, 
and combinations of the three cytokines in the absence of ConA, 
were essentially incapable of stimulating proliferation of either 
DETC or ST. 
In a second series of experiments, we compared DETC to LNT 
and ST in their potential to respond to PMA and ionomycin, agents 
known to bypass the lectin-dependent pathway of lym 
vation [24]. As opposed to ST (Table IV, column 2), w hp 
hocyte acti- 
ich strongly 
* The enrichment procedure used for the various EC subpopulations can- 
not only be used for functional assays of DETC: the LC fraction led to a 
strong proliferative response of purified, allogeneic T cells, and KC readily 
attached to and spread on plastic surfaces (data not shown). The compara- 
tively high background proliferation of KC (column 2) may possibly be due 
to a selective enrichment of those KC that are capable of autocrine growth 
factor production. 
t As can be seen in Tables III, IV, and V, there is a certain variation 
between the single experiments in the magnitude, but not in the pattern, of 
the proliferative activity of DETC induced by the various stimuli. The 
reasons for this variation include 1) the tedious, multistep procedure for 
DETC-enrichment, 2) inevitable variations in cell number/well due to the 
multiple dilution steps of the stock suspension, and 3) differences in the 
quality of DETC enrichment (60% -90%). 
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proliferated in response to both PMA + ionomycin and to PMA + 
rIL-2, DETC (Table IV, columns 1,3) failed to do so. The combina- 
tion of PMA + ionomycin + rIL-2 induced only minimal growth in 
DETC, but stimulated ST to a maximal extent. It also appears that 
IL- 1 may be an ancillary signal in the activation of DETC in that the 
addition of this cytokine greatly increases the roliferative response 
of DETC to PMA i- ionomycin + rIL-2 (Ta lz le IV, columns 1,3). 
Furthermore, even the proliferation of DETC to ConA + rIL-2 is 
regularly enhanced by the addition of rIL-1 (Table IV, columns 1, 
3). These data show that, upon costimulation with either ConA or 
PMA + ionomycin i- rIL-1, IL-2 is an effective means to induce a 
strong proliferative response in DETC. 
It has been reported recently that there exists an alternative 
growth factor to IL-2 involved in the proliferation of both T cell 
precursors and certain peripheral T cells in that the combined use of 
rIL-4 and PMA results in strong proliferation of day 14- 15 fetal 
thymocytes [25,26], PNA-negative adult thymocytes [26], and ac- 
cessory cell-depleted lymph node T cells [27]. We also observed 
that PMA + rIL-4, but not either substance alone, triggered marked 
Table IV. Proliferative Response of DETC and ST to Various 
Stimuli 
Res onding Cell PopuIationsb 
[‘L-I~Thymidine Uptake, cpm 
Supplements Added’ 
Experiment 1 Experiment 2 
DETC’ ST DETC* 
ConA (2.5 pg) + rIL-1 (5 U) 
ConA (2.5 fig) + rIL-2 (100 U) 
ConA (2.5 pug) + PMA (10 ng) 
ConA (2.5 fig) -I- ionomycin 
(500 ne) 
ConA (2.5 pg) -t- Ph4A (10 ng) •t 
ionomycin (500 ng) 
ConA (2.5 pg) + rIL-1 (5 U) + 
rIL-2 (100 U) 
ConA (2.5 fig) -I- rIL-1 (5 U) + 
PMA (10 ng) 
ConA (2.5 pup) + rIL-1 (5 U) i- 
PMA (10 ng) + ionomycin 
(500 ng) 
ConA (2.5 pg) + rIL-2 
(100 U) + PMA (10 ng) 
ConA (2.5 pg) -I- rIL-2 
(100 U) + ionomycin (500 U) 
rIL-1 (5 U) + rIL-2 (100 U) 
rIL-1 (5 U) + PMA (10 ng) 
r&l (5 U) + ionomycin 
(500 ng) 
rIL-1 (5 U) + PMA (10 ng) + 
ionomycin (500 ng) 
rIL-1 (5 U) + rIL-2 (100 U) + 
PMA (10 ng) 
rIL-1 (5 U) + rIL-2 (100 U) + 
ionomycin (500 ng) 
rIL-1 (5 U) + rIL-2 (100 U) + 
PMA (10 ng) + ionomycin 
(500 ng) 
rIL-2 (100 U) -t PMA (10 ng) 
rIL-2 (100 U) + ionomycin 
(500 ng) 
rIL-2 (100 U) + PMA (10 ng) + 
ionomycin (500 ng) 
PMA (10 ng) + ionomycin 
456’ 1,319 
22,218 75,533 
576 1,953 
306 278 
803 131,181 
25,061 79,860 
715 3,037 
574 162,166 
8,782 135,678 
22,325 26,431 
964 708 
392 1,211 
296 84 
428 100,889 
280 62,837 
1,660 5,152 
7,922 142,691 
497 30,022 
465 2,868 
2,560 160,991 
229 142,590 
276 568 
865 
14,306 
243 
316 
658 
17,563 
407 
336 
6,405 
18,530 
1,373 
746 
288 
866 
1,408 
2,123 
4,806 
676 
441 
2,117 
469 
273 
a cpm obtained after addition of either ConA (2.5 fig), rIL-1 (5 U), rIL-2 (100 U), 
PMA (10 ng), or ionomycin (500 ng) were consistently < 700 in the case of DETC and 
< 1400 in the case of ST. 
b cells were seeded at 5 X lo3 cells/well. 
c Contained 77% Thy-l+ cells. 
d Contained 65% Thy-l+ cells. 
c SEM were regularly < 15% and are omitted for clarity. 
Table V. DETC Fail To Proliferate to PMA and rIL-4 
Res nding Cell Populationsa 
[)I-&hymidine Uptake, cpm 
Experiment 1 Experiment 2 
Supplements Added DETCb LNT DETC’ 
rIL-1 (5 U) 120* 70 1,395 
rIL-2 (100 U) 810 1,612 2,103 
rIL-4 (200 U) 411 85 2,329 
ConA (2.5 pg) 193 41 301 
ConA (2.5 pg) + rIL-1 (5 U) 175 73 833 
ConA (2.5 pg) + rIL-2 (100 U) 39,074 3,791 61,845 
ConA (2.5 pg) + rIL-4 (200 U) 294 1,750 3,427 
PMA (10 ng) 577 1,114 2,289 
PMA (10 ng) + rIL-1 (5 U) 372 980 1,250 
PMA (10 ng) + rIL2 (100 U) 1,039 28,328 1,898 
PMA (10 ng) + rIL-4 (200 U) 604 7,946 1,335 
PMA(lOng)+rIL-1(5U)+ 846 10,069 1,490 
rIL-4 (200 U) 
PMA (10 ng) + rIL-2 (100 U) + 2,511 49,444 2,486 
rIL-4 (200 U) 
Medium 283 59 385 
* Cells were seeded at 5 X lo3 cells/well. 
b Contained 86% Thy-l+ cells. 
c Contained 90% Thy-l+ cells. 
d SEM were regularly < 15% and are omitted for clarity. 
proliferation in LNT but, in repeated experiments, consistently 
failed to stimulate a growth response in DETC (Table V). 
Phenotypic Analysis of Proliferating DETC Phenotypic 
screening of either DETC or ST upon stimulation with ConA (2.5 
p 
B 
/ml) + rIL-2 (100 U/ m 1) was performed 6 d after the initiation 
o the cultures. FACS analysis (Fig 2A) revealed that thevast major- 
ity of proliferating DETC were strongly Thy-l + and CD45+. Al- 
though the search for CD5 and CD4 antigens yielded negative 
results, a varying percentage (ranging from 0% - 24%) of cells ex- 
pressed surface-bound CD8 anti ens in three different ex eriments. 
This phenotypic profile is pro oundly different from t B f: at of ST, 
which predominantly contained CD5+ cells (Fig 2B). 
In the presence, but not in the absence, of CAS (20%)-containing 
media, vi 
absence o fg 
orous proliferation of DETC can be maintained in the 
feeder cells or Ia+ accessory cells, or both, for prolonged 
A B 
Figure 2. Phenotypic analysis of short-term cultured DETC as compared 
to ST. After 6 d of continuous stimulation with ConA and rIL-2, cells were 
reacted with a panel of monoclonal antibodies using an indirect immunoflu- 
orescence procedure and analyzed by flow cytometry. Dead cells were ex- 
cluded by propidium iodide staining. Arrows denote the position of the 
cut-off channel fixed with the negative controls. DETC (A) are strongly 
Thy-l+ and CD45+, but completely lack CD4 and CD5 antigens. CD8 
antigens are present on a smaI1 subpopulation of proliferating cells (- 24%). 
In contrast, the vast majority (85%) of proliferating ST (B) express CD5 
antigens; CD4+ and CD8+ antigens were detected on 46% and 51% ofthese 
cells, respectively. 
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periods of time (Tschachler et al, in preparation) [28]. AS opposed to 
short-term stimulated DETC that contained a variable portion of 
CD~+ cells (see above), culture of these cells for an additional 6 wk 
consistently resulted in a uniform phenotypic profile: CD45+, 
Thy-l+, CD3+, CD5-, CD4-, CD8-, and Ia-(Fig 3). Thus, long- 
term cultured DETC phenotypically resemble their in situ counter- 
part with the notable exception that cultured DETC express IL-2 
receptors as defined by anti-CD25 reactivity (Fig 3). 
DISCUSSION 
In this study, we have demonstrated that DETC, which comprise 
only l%-2% of murine EC, can be greatly enriched for (60% - 
90%) by a combined use of density gradient centrifugation tech- 
niques and removal of other EC populations by osmotic and anti- 
body-dependent complement lysis. These DETC-enriched EC 
were used to study the activation and growth-promoting require- 
ments of DETC. Delivering a variety of T cell activating signals, we 
found 1) that activation requirements of DETC are different from 
those of peripheral T lymphocytes and 2) that, upon continuous 
stimulation with lectin/lymphokine-rich media, a selective propa- 
gation of cells with the essential phenotypic features of DETC can 
be achieved. 
The most prominent difference in activation and growth require- 
ments between DETC and LNT/ST is that, in the absence of T cell 
growth factors, exposure of DETC to a variety of stimuli (r&l, 
ConA, PMA, ionomycin) used either alone or in combination never 
results in a reliable growth response. In sharp contrast, PMA + 
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Pigure 3. Phenotypic analysis of long-term cultured DETC. After 7 wk of 
continuous stimulation with CAS (20%)-containing media, cells were 
reacted with a panel of monoclonal antibodies using an indirect immunoflu- 
orescence procedure and analyzed by flow cytometry. Dead cells were ex- 
cluded by*propidium iodide staining. Arrotbs denoie the position of the 
cut-off channel fixed with the negative controls. Virtually all cells are 
CD45+ (A), Thy-l+ (B), and CD3+ (C), but lack CD5 {D), CD4 (E), CD8 
(F), and Ia (G) antigens. A subpopulation of these cells (27%) bears CD25 
antigens (H). 
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ionomycin induces strong proliferation of LNT and ST. Neverthe- 
less, it appears that both ConA and PMA + ionomycin provide an 
important activation signal for DETC in that, upon addition of 
rIL-2, these cells undergo proliferative activity. Whereas ConA + 
rIL-2 was the most effective stimulus for proliferation, PMA + 
ionomycin + rIL-2 led only to marginal mitotic activity of DETC. 
Repeated experiments showed, however, that the latter response 
could be considerably enhanced by the addition of rIL-1. In fact, 
PMA + ionomycin + rIL-I was the only stimulus that together 
with rIL-2 was effective in bypassing the otherwise obligatory need 
for ConA + IL-2 in growth induction of DETC. This finding can 
be interpreted in several ways. First, it may well be that PMA + 
ionomycin alone render DETC IL-2 responsive to a limited extent 
and that the function of rIL-1, albeit ineffective by itself, is to 
enhance this effect. On the other hand, one should not forget that 
EC even when greatly enriched for DETC still contain considerable 
numbers of KC known to be capable of IL-l production [29]. It is 
thus conceivable that the slight proliferation seemingly induced by 
PMA + ionomycin + rIL-2 alone must be attributed to a costimulat- 
ing effect of KC-derived IL-1 that, in the case of high DETC 
enrichment, would be available in only limited quantities. Excess 
amounts of rIL-1 would then allow optimal proliferation. A similar 
mechanism may actually be operative in the activation of DETC- 
enriched EC by ConA + rIL-2: we have occasionally observed that 
the magnitude of the proliferative response induced by ConA + 
rIL-2 + rIL-I was higher than that seen with ConA + rIL-2 alone. 
Although resident DETC lack IL-2 receptors [6] and do not pro- 
liferate in response to rIL-2 alone, it appears that on delivery of 
appropriate costimulatory signals (ConA or PMA + ionomycin + 
IL-l), IL-2 rather than IL-4 is the critical growth factor for DETC. 
In this regard, DETC differ from CD4-, CD8- (double-negative) 
fetal and adult thymocytes that, u on activation with either ConA 
or PMA, proliferate in response to 1 0th growth factors even though 
the IL-4 response is significantly higher in magnitude than that seen 
with IL-2 [26]. Similarities or differences in activation and growth 
requirements between DETC and double-negative thymocytes 
[30,31] should, h owever, not be overinterpreted. Whereas DETC 
are a homogeneous population of CD3+, TCR y/S+, CD4-, CD8- 
lymphocytes [8,9], CD4-, CD8- thymocytes exhibit a pronounced 
heterogeneity in TCR expression (CD3-, CD3+-TCR r/J+, 
CD3+-TCR (yip’) [13, 32-341. Despite the demonstration of 
IL-2 production by a ConA-stimulated DETC-derived cell line [35] 
and by a ConA- or anti-CD3 e-stimulated DETC-derived T cell 
hybridoma [36], ‘t pp t a ears from this study that freshly isolated, 
activated (ConA or PMA + ionomycin i- IL-l) DETC do not pro- 
duce IL-2 in quantities sufficient to sustain autocrine growth. Actu- 
ally, one wonders whether a putative activation of these cells in vivo 
(e.g., by antigens or by EC-derived cytokines) is indeed followed by 
their proliferation; it appears equally possible that physiologic acti- 
vation of DETC is not reflected in their proliferation but only in the 
induction/generation of as yet undefined secretory and/or effector 
mechanisms. 
Although the occurrence of CD5, CD8, and CD4 antigens has 
never been observed on resident DETC [6,9], it was interesting to 
see that a varying percentage of DETC proliferating in response to 
CAS-containing media expressed CD8 antigens. This, however, 
was a transitory phenomenon as, on continuous stimulation, these 
CD8+ DETC gradually disappeared giving rise finally to cell lines 
displaying the essential features of resident Thy-l+DEC, i.e., 
CD45+, Thy-l+, CD3+, CD5-, CD8-, CD4-, Ia- [28]. Interest- 
ingly, the gradual disappearance of CD8+ DETC coincided with 
the progressive loss of KC “contaminating” freshly isolated DETC. 
Should this coincidence be more than fortuitous, it is conceivable 
that similar to the critical role of the thymic stroma for the matura- 
tion of thymic stem cells [37-391, KC, and possibly also LC, and 
their products may induce maturational events in DETC. The lack 
of further differentiation of DETC into either CD4+ or CD8+ cells 
would then be a consequence of the progressive loss of KC imposed 
by the culture conditions employed. Questions concerning the po- 
tential for differentiation of DETC and the environment necessary 
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for such a hypothetical event are currently under investigation in 
our laboratory. 
We thank Dr. Ethan M. Shevach for helpful suggestions and discussions, Irene 
Assmannforskil@ FACS operation, and Sylvia Hermanekfor excellent secretarial 
assistance in the preparation ofthis manuscript. 
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